Get the Stockscreener App
4.14
0.24%
0.010
After Hours:
4.16
0.02
+0.48%
Anixa Biosciences Inc stock is traded at $4.14, with a volume of 254.32K.
It is up +0.24% in the last 24 hours and up +26.61% over the past month.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
See More
Previous Close:
$4.13
Open:
$4.12
24h Volume:
254.32K
Relative Volume:
1.54
Market Cap:
$136.28M
Revenue:
-
Net Income/Loss:
$-12.48M
P/E Ratio:
-10.62
EPS:
-0.39
Net Cash Flow:
$-7.93M
1W Performance:
-4.39%
1M Performance:
+26.61%
6M Performance:
+48.92%
1Y Performance:
+13.11%
1-Day Range:
$3.83
$4.17
1-Week Range:
$3.83
$4.45
52-Week Range:
$2.07
$4.98
Anixa Biosciences Inc Stock (ANIX) Company Profile
Name
Anixa Biosciences Inc
Sector
Industry
Phone
408-708-9808
Address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Compare ANIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
4.14 | 135.95M | 0 | -12.48M | -7.93M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | Maxim Group | Buy |
| Dec-23-22 | Initiated | Chardan Capital Markets | Buy |
| Apr-12-21 | Initiated | H.C. Wainwright | Buy |
Anixa Biosciences Inc Stock (ANIX) Latest News
How to build a dashboard for Anixa Biosciences Inc. stock2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Is Anixa Biosciences Inc. stock a contrarian buyMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
Backtesting results for Anixa Biosciences Inc. trading strategiesWall Street Watch & Daily Stock Trend Watchlist - newser.com
Is Anixa Biosciences Inc. trending in predictive chart modelsPortfolio Performance Report & Consistent Return Investment Signals - newser.com
Is Anixa Biosciences Inc. stock supported by strong cash flowsJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Will Anixa Biosciences Inc. stock benefit from commodity prices2025 Performance Recap & Stepwise Trade Execution Plans - newser.com
Anixa Biosciences Inc. stock prediction for this weekForecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Is Anixa Biosciences Inc. (CY71) stock nearing a technical breakoutPortfolio Return Summary & Weekly Momentum Picks - newser.com
How Anixa Biosciences Inc. stock reacts to oil pricesQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
How supply chain issues affect Anixa Biosciences Inc. stock2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
How Anixa Biosciences Inc. (CY71) stock reacts to fiscal policies2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Is Anixa Biosciences Inc. (CY71) stock a safe buy pre earnings2025 Trade Ideas & Fast Gain Stock Tips - newser.com
Key metrics from Anixa Biosciences Inc.’s quarterly dataPortfolio Gains Report & Real-Time Volume Spike Alerts - newser.com
Will Anixa Biosciences Inc. stock outperform tech sector in 2025Weekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com
Developing predictive dashboards with Anixa Biosciences Inc. dataBull Run & Weekly High Momentum Picks - newser.com
Intraday pattern recognizer results for Anixa Biosciences Inc.Trade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Using data filters to optimize entry into Anixa Biosciences Inc.2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Anixa Biosciences, Inc. (ANIX) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Anixa Biosciences Inc Stock (ANIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):